Company Filing History:
Years Active: 2021
Title: Lijuan Zhai: Innovator in Pharmaceutical Chemistry
Introduction
Lijuan Zhai is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of new compounds for clinical applications. His work focuses on enhancing the stability and efficacy of pharmaceutical agents.
Latest Patents
Lijuan Zhai holds a patent for a crystalline form of an alkynyl pyridine prolyl hydroxylase inhibitor. This invention includes a method for preparing the crystalline form, which is represented by a specific formula. The new crystalline form demonstrates good stability, making it a promising candidate for clinical treatment.
Career Highlights
Zhai is associated with Jiangsu Hengrui Medicine Company Ltd., where he continues to advance his research and development efforts. His innovative approach has led to breakthroughs in the pharmaceutical industry, particularly in the synthesis of stable compounds.
Collaborations
Zhai collaborates with esteemed colleagues, including Zhenxing Du and Likun Wang, who contribute to his research endeavors. Their combined expertise enhances the potential for successful outcomes in their projects.
Conclusion
Lijuan Zhai's contributions to pharmaceutical chemistry exemplify the impact of innovative research on clinical treatments. His work not only advances scientific knowledge but also holds promise for improving patient care.